Skip to main content
Log in

Nitronaproxen

AZD 3582, HCT 3012, Naproxen Nitroxybutylester, NO-Naproxen

  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Table II

References

  1. Cuzzolin L, Conforti A, Adami A. Anti-inflammatory potency and gastrointestinal toxicity of a new compound, nitronaproxen. Pharmacological Research 31: 61–65, Jan 1995

    Article  PubMed  CAS  Google Scholar 

  2. NicOx SA. NicOx to Reacquire Rights to CINOD Class of Drugs From AstraZeneca. Media Release: 23 Sep 2003. Available from URL: http://www.nicox.com

    Google Scholar 

  3. NicOx SA. NicOx Completes Enrolment of Phase 3 Trial for HCT 3012 in Osteoarthritis Ahead of Schedule. Media Release: 24 May 2006. Available from URL: http://www.nicox.com

    Google Scholar 

  4. NicOx SA. NicOx Initiates New Trial to Establish HCT 3012 as Osteoarthritis Treatment With Beneficial Blood Pressure Profile. Media Release: 4 May 2006. Available from URL: http://www.nicox.com

    Google Scholar 

  5. NicOx SA. NicOx Announces Initiation of Phase 3 Trial For HCT 3012 in Osteoarthritis. Media Release: 20 Dec 2005. Available from URL: http://www.nicox.com

    Google Scholar 

  6. NicOx SA. NicOx Reports 2004 Financial Results. Media Release: 1 Mar 2005. Available from URL: http://www.nicox.com

    Google Scholar 

  7. Nicox. NicOx Announces Positive Evaluation of Overall Phase II Clinical Results on AZD3582 by a U.S. Consultant Advisory Board. Media Release: 27 Jan 2004. Available from URL: http://www.nicox.com

    Google Scholar 

  8. NicOx. NicOx Initiates Clinical Study to Evaluate HCT 3012 Effects on Blood Pressure Vs. Rofecoxib. Media Release: 8 Sep 2004. Available from URL: http://www.nicox.com

    Google Scholar 

  9. Lohmander LS, McKeith D, Svensson O, et al. A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis. Annals of the Rheumatic Diseases 64: 449–456, No. 3, Mar 2005

    Article  PubMed  CAS  Google Scholar 

  10. Schnitzer TJ, Kivitz AJ, Lipetz RS, et al. A phase II study of the efficacy and safety of AZD3582, a cinod, in subjects with osteoarthritis of the knee. Annals of the Rheumatic Diseases 63 (Suppl. 1): 62–63, Jul 2004

    Google Scholar 

  11. NicOx SA. NicOx Announces Preliminary Review of Data from Phase II Study of AZD3582. Media Release: 11 Mar 2003. Available from URL: http://www.nicox.com

    Google Scholar 

  12. NicOx SA. Further Update on AZD3582 Following Meeting of Independent Panel. Media Release: 26 Mar 2003. Available from URL: http://www.nicox.com

    Google Scholar 

  13. Fagerholm U, Andersson L, Swedmark S, et al. Pharmacokinetics of AZD3582, a COX-inhibiting nitric oxide donator, in animals suggest potential clinical utility as an analgesic drug. Pharmacologist 44 (Suppl. 1): 171, 2002

    Google Scholar 

  14. Schnitzer T, Ballabio M, Bonizzoni E. AZD3582, a CINOD, differs significantly from rofecoxib in having a neutral effect on blood pressure in patients with osteoarthritis: results of a randomized, controlled trial. Arthritis and Rheumatism 50 (Suppl.): 347, No. 9, Sep 2004

    Google Scholar 

  15. Cirino G, Wheeler-Jones CPD, Wallace JL. Inhibition of inducible nitric oxide synthase expression by novel nonsteroidal antiinflammatory derivatives with gastrointestinal-sparing properties. British Journal of Pharmacology 117: 1421–1426, Apr 1996

    Article  PubMed  CAS  Google Scholar 

  16. Cirino G, Calignano A, Iannaro A. NO-naproxen modulates inflammation pain and T cell response in rat Freund’s adjuvant arthritis. Mediators of Inflammation 8 (Suppl. 1): 59, 1999

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nitronaproxen. Drugs in R D 7, 262–266 (2006). https://doi.org/10.2165/00126839-200607040-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200607040-00007

Keywords

Navigation